Related Experiment Video
Updated: Jun 16, 2026
10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
PET and PET/CT in endocrine tumours
Robert Dudczak1, Tatjana Traub-Weidinger
1Department of Nuclear Medicine, Medical University of Vienna, Austria. robert.dudczak@meduniwien.ac.at
European Journal of Radiology
|January 22, 2010
Summary
Positron Emission Tomography (PET) imaging, enhanced by hybrid PET/CT systems and new radiopharmaceuticals, is increasingly vital in endocrinology. This technology offers superior image quality and quantification for diagnosing endocrine tumors.
Area of Science:
- Nuclear Medicine
- Endocrinology
- Radiopharmaceuticals
Background:
- Positron Emission Tomography (PET) technology provides functional information and superior image quality.
- Hybrid PET/CT systems and novel PET radiopharmaceuticals have enhanced nuclear medicine's role in diagnostics.
- Nuclear medicine is gaining diagnostic impact in endocrinology.
Purpose of the Study:
- To review imaging strategies using PET and PET/CT in endocrine tumors.
- To discuss various radiopharmaceuticals and their cell uptake mechanisms.
- To evaluate the diagnostic value of PET and PET/CT for endocrine tumors, excluding differentiated thyroid carcinomas.
Main Methods:
- Review of current literature on PET and PET/CT imaging in endocrinology.
- Analysis of different PET radiopharmaceuticals and their biological mechanisms.
- Assessment of diagnostic performance in endocrine tumor detection and characterization.
Main Results:
- PET and PET/CT offer significant advancements in visualizing and quantifying endocrine tumors.
- Novel radiopharmaceuticals demonstrate improved specificity and sensitivity for certain endocrine conditions.
- The integration of PET/CT enhances diagnostic accuracy compared to conventional imaging.
Conclusions:
- PET and PET/CT are becoming indispensable tools in the diagnosis and management of endocrine tumors.
- The development of targeted radiopharmaceuticals continues to expand the utility of nuclear medicine in endocrinology.
- Further research is warranted to optimize imaging protocols and expand applications.
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...